Arcana Collective Unites Legacy Cannabis Breeders and Respected Business Leaders to “Advance Genetics and Elevate the Industry”

The group says its mission is to restore authenticity, elevate quality, and reconnect the legal market with the values that defined the plant long before commercialization. The Shelton, Washington–based company is positioning itself as both a nursery sciences hub and a guardian of iconic cannabis strains. Its state-of-the-art facility, called “Ghost Town,” integrates clone and tissue culture technology with organic, science-based soils to deliver healthier genetics at lower costs. The facility will also serve as the base for Arcana’s Nursery Sciences division, which is expected to roll out in fall 2025 with a library of seeds, slips, and tissue culture clones, along with genetic licensing opportunities.

What sets Arcana apart is the pedigree of its members. The Collective includes Josh D, the cultivator credited with preserving OG Kush in the 1990s; OG Ghost, who popularized Ghost OG and maintains a vast library of self-bred strains; Ras Kaya Paul of Pacific NW Roots, an award-winning regenerative farmer and hash maker; Chemdog, the breeder behind Chem91 and its famed descendants; Suny Cheba of TGA, known for influential strains like Double Purple Doja; and Rev Fuji, developer of elite genetics like Kurple Fantasy, a High Times Cannabis Cup winner.

Backing these breeders is an executive team led by Chairman and Cofounder Michael Klein, an entrepreneur who also cofounded soil company bio365, and CEO and Cofounder Andrew Berman, a longtime cannabis executive with experience at Harborside and Flora California. Together, they say the goal is to marry authentic genetics and cultivation wisdom with business expertise capable of sustaining long-term growth.

The company is also introducing what it calls its PAC program—Permission, Acknowledgement, Compensation—designed to protect breeders whose work has historically been used without credit or pay. The program ensures that breeders give consent for their genetics to be incorporated, receive proper recognition, and share in financial success.

Klein said Arcana was founded to fix what he sees as failings in the modern marijuana market. “Legal cannabis has fallen short of its promise. Severed from a foundational connection to the plant and the values that initially defined it, the sector has been marked by poor quality, inauthenticity, and limited success. Arcana was founded to right these wrongs by respecting the plant and those closest to it.”

Berman added that technology will play a key role in strengthening that respect. “Through DNA gene sequencing, we can authenticate every strain and its heritage, so consumers know exactly what they’re getting,” he said. That approach, he noted, also allows the Collective to assess stability, provide predictability, and breed for traits that carry the most benefit to growers and consumers alike.

With some of the most respected breeders in marijuana’s history at the helm, Arcana Collective is positioning itself not just as another cannabis company but as a steward of the plant’s most important genetics, working to ensure they remain accessible, verifiable, and protected for future generations.